Darunavir

Product NDC
70771-1745
11-digit product format
707711745
Labeler code
70771
Product ID
70771-1745_1b288e91-dedb-465d-8c45-eb464dc72e89
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Darunavir
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Zydus Lifesciences Limited
Application
ANDA214085
Marketing category
ANDA
Marketing start
2024-05-01
Substance
DARUNAVIR
Active strength
600 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
YO603Y8113DARUNAVIR206361-99-1DARUNAVIR

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70771-1745-570771174505500 TABLET, FILM COATED in 1 BOTTLE (70771-1745-5) 2024-05-01NoNoHistorical
70771-1745-67077117450660 TABLET, FILM COATED in 1 BOTTLE (70771-1745-6) 2024-05-01NoNoHistorical
70771-1745-870771174508180 TABLET, FILM COATED in 1 BOTTLE (70771-1745-8) 2024-05-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Darunavir TabletsZydus Lifesciences Limited2024-04-29HUMAN PRESCRIPTION DRUG LABEL1